Equities researchers at Truist Financial assumed coverage on shares of Boston Scientific (NYSE:BSX – Get Rating) in a report released on Wednesday, FinViz reports. The brokerage set a “buy” rating and a $52.00 price target on the medical equipment provider’s stock. Truist Financial’s target price points to a potential upside of 17.14% from the company’s […]
Sumitomo Mitsui Trust Holdings Inc. lowered its position in Boston Scientific Co. (NYSE:BSX – Get Rating) by 4.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,901,733 shares of the medical equipment provider’s stock after selling 166,700 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Boston Scientific were worth $165,746,000 as […]
Equities research analysts forecast that Boston Scientific Co. (NYSE:BSX – Get Rating) will post earnings per share (EPS) of $0.39 for the current quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Boston Scientific’s earnings, with estimates ranging from $0.38 to $0.39. Boston Scientific posted earnings per share of $0.37 in the same […]
Bessemer Group Inc. increased its position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 13.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,413 shares of the medical equipment provider’s stock after purchasing an additional 979 shares during the […]
Amplius Wealth Advisors LLC bought a new position in Boston Scientific Co. (NYSE:BSX – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,902 shares of the medical equipment provider’s stock, valued at approximately $80,000. Other hedge funds also recently modified their holdings of […]